OUR COMPANY
CONTACT
Home
Products
How the solution works
UNEEG™ SubQ
24/7 EEG™ SubQ
UNEEG™ MyConnect
UNEEG™ EpiSight
IFU
Clinical Publications
Epilepsy
EEG Research
Diabetes
Epilepsy
EAR-EEG
News and press
News
Events
Media Library
Media / Products
Media / Management
Media / Lifestyle
Press contact
News and press
News
First U.S. patient initiated in pivotal multi-center study for U.S. approval of the UNEEG EpiSight™ solution: a disruptive technology that may advance biomarker-based therapy for people with epilepsy
15-06-2021
UNEEG medical, a company pioneering technologies that collect, monitor, and analyze brain activity, to improve diagnostics and treatment within epilepsy, announce initiation of the first U.S. patient in the U.S. pivotal clinical evaluation of the company’s flagship program for ultra long-term electroencephalogram (EEG) recording.
The UNEEG EpiSight
™
solution has been available in the European Union since 2019, and the pivotal U.S. study will further expand the in-use validation ongoing at major epilepsy hospitals in Europe.
Read the press release here